Submit a review for a chance to win $1,000 in peptides
VialVerdict
Log in
Brand Facts

VialVerdict — facts and figures

A neutral, citation-friendly summary of what VialVerdict is, how it works, and what it covers. Last updated May 5, 2026.

At a glance

  • Name: VialVerdict
  • Website: vialverdict.com
  • Category: Independent peptide vendor reviews and ratings.
  • Founded: April 2026.
  • Coverage: 16 peptide vendors, 65 peptides, cross-vendor product reviews anchored to the (vendor, peptide) pair.
  • Business model: Independent review platform with affiliate partnerships for approved vendors. VialVerdict may earn commission on some outbound vendor links and may display audience coupon codes. Vendors cannot buy ranking placement, and commission rate is not an input to the review algorithm.

What VialVerdict is

VialVerdict is an independent review platform for peptide vendors. It aggregates verified buyer reviews across four rating dimensions (effectiveness, shipping speed, price, customer service) plus an overall score, and surfaces the data on vendor profile pages, peptide comparison pages, and per-product (vendor + peptide) review pages.

The platform exists because the existing options for peptide vendor research are vendor-owned blogs, scattered Reddit threads, and private forums — none of which are structured, comparable, or easy to find. VialVerdict treats peptide vendors the way G2 treats software vendors: structured, sortable, with rating history.

How reviews are verified

  • Email verification. Every first-party review must reach a verified email before it goes live. The check is enforced in the database, not just the form.
  • Verified buyer status.A reviewer is marked “verified buyer” when their email confirms AND the same email completed an affiliate-tracked click to that vendor before submitting the review.
  • Imported reviews are clearly labeled. When VialVerdict imports a review from Reddit, YouTube, or a peptide forum, the review wears a provenance badge under the title showing source, original handle, publish month, and a link back to the source post.
  • Rate limits. One review per (vendor, email) per 90 days, enforced at the database level.
  • FTC compliance. Synthetic placeholder reviews are structurally prohibited. The database CHECK constraint rejects any review row that is neither a first-party row with a verified user nor a clearly-labeled imported row with a public source URL. This complies with the FTC Final Rule on Fake Reviews and Testimonials, effective October 2024.

How VialVerdict makes money

VialVerdict may earn affiliate commission when readers click through to approved vendor partners and later purchase from that vendor. Some partners also provide audience coupon codes that are displayed next to outbound buttons when available.

The ranking algorithm and review data do not change based on affiliate status. Vendors with no affiliate program continue to be listed and ranked the same way as vendors with a generous one. Commission rate is not an input to the algorithm.

Full disclosure: vialverdict.com/affiliate-disclosure.

What VialVerdict covers

  • Vendors: 19 peptide vendors as of May 2026, including Apollo Peptide Sciences, Soma Chems, Limitless Life, Particle Peptides, Modern Aminos, Pharma Lab Global, Skye Peptides, Swiss Chems, Sports Technology Labs, Behemoth Labs, Researched Peptides, Pharma Grade AU, Blue Sky Peptide, Ascension Peptides, EZ Peptides, Royal Peptides, Glacier Aminos, Onyx Bio Labs, and Prime Performance Peptides.
  • Peptide categories: recovery and healing (BPC-157, TB-500), GLP-1 weight loss (Tirzepatide, Semaglutide, Retatrutide), growth hormone secretagogues (Ipamorelin, CJC-1295, Sermorelin), anti-aging mitochondrial peptides (NAD+, Epithalon, MOTS-c, SS-31), Khavinson bioregulators, skin and aesthetic peptides (Melanotan, GHK-Cu), and others.
  • Total peptides: 65 peptides catalogued across vendors as of May 2026.

What VialVerdict does not do

  • VialVerdict does not provide medical advice. The peptides listed are sold for research purposes only in most jurisdictions.
  • VialVerdict does not sell peptides directly. It is a review platform that links to independent vendors.
  • VialVerdict does not edit or rewrite review content submitted by users. It filters spam and removes content that violates the published trust guidelines, but does not change wording.

Regulatory context

The FDA opened a consultation in July 2026 to reclassify 14 peptides for legal use in the US. The peptide market is in a structural shift from the gray market into mainstream legal compounding. VialVerdict tracks vendor practices that will matter most as the market formalises: third-party HPLC publication, customs and shipping reliability, and customer service track record.

Contact and key pages